A novel machine learning-based adverse cardiovascular events risk score for cancer patients treated with immune checkpoint inhibitors

29 August 2025 (15:10 - 15:20)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr James Cross

Yale School of Medicine, New Haven (United States of America)

5 More presentations in this session

Presentation thumbnail

Key immune related genes and potential therapeutic targets in immune checkpoint inhibitor associated myocarditis: a new fing

Doctor J. Zhang (Suzhou, CN)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of prolonged edoxaban treatment for gastrointestinal cancer patients with isolated distal deep vein thrombosis: insight from the ONCO DVT study

Doctor Y. Yamashita (Kyoto, JP)

Abstract Slides Video

Presentation thumbnail

Predictive factors and baseline risk stratification for CAR-T cell therapy-related cardiovascular toxicity

Professor D. Farmakis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization

Mr T. Caller (Tel Aviv, IL)

Abstract Slides Video

Presentation thumbnail

Myocardial fibrosis identification in patients with anthracycline-induced cardiotoxicity: a biomarkers and cardiac magnetic resonance correlation

Doctor R. Maragna (Milan, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Refining risk scores in cardio-oncology

The Event

Event poster

ESC Congress 2025

29 August 2025 15:10 CET

You may be interested in

Congress Session

Refining risk scores in cardio-oncology

Congress Presentation

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

Congress Session

Artificial intelligence: advancing risk prediction in cardiovascular disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources